Genenta Science Announces Extension Of Licence Agreement With Ospedale San Raffaele
Genenta Announced That The Licence Agreement With Ospedale San Raffaele (Osr) Has Been Amended And Restated To Provide Access To All Solid Tumour Indications, Subject To Governmental Consent As Described Below.This Agreement Will Strengthen The Breadth Of Ip Position And Confirm Options For Combination Treatments And Other Potential Payloads. Promising Preliminary Clinical Data Generated In The Ongoing Study Of The First Solid Tumour Indication In Glioblastoma Supports Decision To Expand The Licence To Cover All Solid Tumours And Primes Ability To Impact Other Hard-To-Treat Cancer Types.The Amended And Restated Licence Agreement Reinforces Genenta'S Long-Term Strategic Relationship With Osr, Contributing To The Unique And Valuable Expertise For The Development Of Cell-Based Therapies
Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!
